TCM

TCG Crossover Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 698.5%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+698.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.02B
AUM Growth
+$989M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
48
New
Increased
Reduced
Closed

Top Buys

1
+$62.3M
2
+$57.4M
3
+$42.1M
4
ADCT icon
ADC Therapeutics
ADCT
+$40.6M
5
IMVT icon
Immunovant
IMVT
+$37M

Top Sells

1
+$62.7M
2
+$34.2M
3
+$30.7M
4
COGT icon
Cogent Biosciences
COGT
+$26.1M
5
ATXS
Astria Therapeutics
ATXS
+$20.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
1
Abivax
ABVX
$9.12B
$959M 31.74%
7,111,596
COGT icon
2
Cogent Biosciences
COGT
$6.27B
$208M 6.9%
5,868,162
-930,000
CGON icon
3
CG Oncology
CGON
$4.86B
$152M 5.04%
3,670,206
TNGX icon
4
Tango Therapeutics
TNGX
$1.54B
$113M 3.74%
12,762,094
+4,225,898
CNTA
5
Centessa Pharmaceuticals
CNTA
$3.96B
$107M 3.55%
4,286,480
+1,150,000
DYN icon
6
Dyne Therapeutics
DYN
$2.62B
$90.3M 2.99%
4,615,144
RAPT icon
7
RAPT Therapeutics
RAPT
$1.68B
$87.5M 2.89%
2,582,408
+946,133
TYRA icon
8
Tyra Biosciences
TYRA
$1.77B
$76.2M 2.52%
2,898,103
AMLX icon
9
Amylyx Pharmaceuticals
AMLX
$1.68B
$75.4M 2.5%
6,243,812
SVRA icon
10
Savara
SVRA
$1.25B
$74.5M 2.47%
12,362,205
GLUE icon
11
Monte Rosa Therapeutics
GLUE
$1.38B
$72.5M 2.4%
+4,622,151
OCUL icon
12
Ocular Therapeutix
OCUL
$2.31B
$69.7M 2.31%
5,740,231
-377,001
DNTH icon
13
Dianthus Therapeutics
DNTH
$2.41B
$69.1M 2.29%
1,676,624
EYPT icon
14
EyePoint Inc
EYPT
$1.56B
$65.3M 2.16%
3,572,335
GPCR icon
15
Structure Therapeutics
GPCR
$4.48B
$64M 2.12%
920,857
-142,143
SYRE icon
16
Spyre Therapeutics
SYRE
$3.34B
$62.3M 2.06%
1,900,582
+800,000
FULC icon
17
Fulcrum Therapeutics
FULC
$532M
$59.4M 1.97%
5,250,000
LQDA icon
18
Liquidia Corp
LQDA
$2.67B
$59M 1.95%
1,710,084
BHVN icon
19
Biohaven
BHVN
$1.53B
$52.3M 1.73%
+4,631,317
IMVT icon
20
Immunovant
IMVT
$5.71B
$42.2M 1.4%
+1,660,933
KOD icon
21
Kodiak Sciences
KOD
$1.66B
$40.4M 1.34%
1,445,538
+300,000
ADCT icon
22
ADC Therapeutics
ADCT
$520M
$40.2M 1.33%
11,390,175
+10,000,000
LBRX
23
LB Pharmaceuticals
LBRX
$590M
$38.8M 1.29%
1,745,015
-1
XNCR icon
24
Xencor
XNCR
$866M
$37.5M 1.24%
2,452,138
RVMD icon
25
Revolution Medicines
RVMD
$19.7B
$34.8M 1.15%
436,473
1
2